ImmuLogic Pharmaceutical Corp. (Abridged) Harvard Case Solution & Analysis

ImmuLogic Pharmaceutical Corp. (Abridged) Case Solution

ImmuLogic Pharmaceutical Corp., a development-stage medical business, is considering making a first offering of usual equity. The reasonsto get and issues of high-technology set-ups are checked out. The obstacles presented by "windows" for common products are feature.

corporation case solution" width="288" height="288" /> immulogic pharmaceutical corporation case solution

This is just an excerpt. This case is about  FINANCE & ACCOUNTING

PUBLICATION DATE: December 09, 1992

Related Case Solutions & Analyses:

The North Side Childrens Agency (A): Finances versus Mission Dows Bid for Rohm and Haas Pudong New Area of Shanghai Ken Traub at American Bank Note Holographics Universal Display Corporation: Go Long or Short? Bonnie Road Corporate Finance Project 4M: Four-Markets Analysis for Emerging Economies Alleged Accounting Fraud at Nortel Networks Corporation AKAM DCF Model